Drugs / tetracyclin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00336154 | ? → Jun 2006 | epidermolysis bullosa | Rambam Health Care Campus | Withdrawn | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT06759610 Comparator | Feb → Aug 2024 | ameloblastoma | Minia University | Completed | No outcome recorded |
| — | NCT03431688 Comparator | Oct 2018 → Oct 2020 | Helicobacter pylori infectious disease | Kangdong Sacred Heart Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetracyclin | “treatment with PPI, metonidazole, bismuth, tetracyclin” NCT03431688 ↗ |
| Action | Inhibit | “Tetracyclines are effective inhibitors of mammalian MMPs.” NCT06759610 ↗ |